Cedars Sinai

Clinical care:cedars-sinai has been named the #1 hospital in California and #2 hospital in the nation in u.s. news & world report's "2022-2023 best hospitals" rankings and placed among the very best in 11 specialties nationwide. As such, Cedars-Sinai is deeply committed to leadership and excellence in delivering quality patient care for all, expanding the horizons of Medical knowledge through innovative biomedical research, providing outstanding education and training for physicians and other (see schedule o for continuation)(continued)healthcare professionals, improving the health status of the neediest in its community, and partnering with donors and organizations to support these pillars of its mission.in fiscal year 2022, Cedars-Sinai Medical Center reported 288,474 inpatient days (approximately 790 per day), and 955,200 outpatient visits. There were 45,498 inpatient admissions, and 88,260 emergency department visits. Cedars-Sinai's emergency department serves the entire region as one of only four remaining level i trauma centers in los angeles county (and the only one not operated by the government), with staffing and technology to treat the most severely injured accident and natural disaster victims. As one of the largest academic Medical centers in the western united states, Cedars-Sinai provides many highly specialized services that are not available at most other hospitals, and which require a significant infrastructure of technology and expert staffing. For example, in fiscal year 2022, Cedars-Sinai performed 107 heart transplants and 73 lung transplants, among the most of any hospital in the world. Patients with advanced heart disease come to Cedars-Sinai because of the expertise of its cardiologists and cardiac surgeons, and because Cedars-Sinai has the infrastructure to offer more heart transplants than any other hospital as well as newer technologies to treat advanced heart disease. Cedars-Sinai's services for cancer patients are similarly broad in scope and size. At any given time, patients have access to approximately 200 clinical trials through Cedars-Sinai cancer. In fiscal year 2022, Cedars-Sinai's oncology experts treated 238,528 patients for over 60 types of cancer at more than 10 locations throughout greater los angeles.cedars-sinai guerin children's, a new 26-bed facility for advanced pediatric care, opened in summer 2022, providing a seamless continuum of primary and specialty care for hospitalized patients and outpatients as they grow from newborns to adolescents to adults.

Training for physicians and other health professionals:from the classroom to the clinic, from high schoolers to graduate students and residents, Cedars-Sinai is an epicenter of education, mentoring and inspiration for young people and future leaders. Cedars-Sinai's educational mission is key to ensuring a legacy of high-quality science and patient care for generations to come. In fiscal year 2022, Cedars-Sinai's net cost of providing these training programs was $98,416,878. (see schedule o for continuationcontinuedcedarssinai offers 15 residency programs and 89 fellowship programs in a variety of highly ranked specialties. In fiscal year 2022, 23% of interviews for Medical residencies at Cedars-Sinai were offered to underrepresented students, and 17% of those candidates matched in one of its programs. Sixteen students graduated in Cedars-Sinai's master's degree programs in health delivery science and magnetic resonance imaging, and six more graduated from Cedars-Sinai's phd in biomedical sciences program. The geri and richard brawerman nursing institute welcomed a record number of new nurses to the new-graduate registered nurse residency program, which helps nurses throughout their first year of professional practice.

Research:in Cedars-Sinai laboratories and clinics, investigators develop and test new ideas, explore the genetic underpinnings of disease, realize the potential of stem cells, leverage technology, and assess how gender and metabolism affect health. Cedars-Sinai pushes forward the frontiers of biomedical knowledge to pioneer precision therapies, novel diagnostic tools and sophisticated new surgical techniques to enhance the lives of men, women and children worldwide. (see schedule o for continuation)(continued)this past fiscal year, Cedars-Sinai scientists and physician-researchers were engaged in more than 2,000 active research projects and 597 clinical trials aimed at advancing new treatments for patients suffering from heart disease, brain disorders, cancers and innumerable other conditions. Cedars-Sinai is also pioneering research that improves the quality and efficiency of healthcare delivery in underserved communities. Cedars-Sinai physician scientists published over 2,800 peer-reviewed faculty publications. While some of these research projects are funded in part or in whole by funds from the national institutes of health or other government agencies, many are funded by cedars-sinai, especially seed grants to support innovative new research. In fiscal year 2022, Cedars-Sinai's total cost of research was $113,283,740, including 190 national institutes of health grants and other grants totaling $148,516,119.